Patient Forms & Intake Documents

Complete your forms online before your appointment to save time and ensure a smooth, efficient visit. Access all required documents in one place and submit them securely so our team can focus on your care from the moment you arrive.

The following conditions are contraindications and may prevent treatment at this time:

 

• Pregnant or nursing
• Amyotrophic lateral sclerosis
• Myasthenia gravis
• Keloid scarring
• Other neuromuscular disorders

With my signature below, I confirm that I have accurately completed the above information to the best of my knowledge. I agree to notify the provider of any other relevant information that may affect my procedure, including any changes to the information above. I agree to communicate with my provider about any pain or discomfort experienced during or after the procedure. I release my provider of any and all liability of injury or damages that may arise because I have not represented my medical history accurately.

NOTICE OF PRIVACY PRACTICES

THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN ACCESS THIS INFORMATION PURSUANT TO FEDERAL REGULATIONS. PLEASE REVIEW IT CAREFULLY.


1. INTRODUCTION

At Head2ToeHealth, LLC Practice, we understand that medical information about you and your health is personal. We are committed to protecting medical information about you.

We create a record of the care and services you receive directly from one of our physicians. We need this record to provide you with quality care and to comply with certain legal requirements.

This Notice of Privacy Practices (“Notice”) applies to all the records of your care generated by Practice.

This Notice will tell you about the ways in which Practice may use and disclose your protected health information (“PHI”). This Notice also describes your rights and certain obligations Practice has regarding the use and disclosure of PHI.


2. REGULATORY REQUIREMENTS

Practice is required by law to maintain the privacy of your PHI, to provide individuals with notice of Practice’s legal duties and privacy practices with respect to PHI, and to abide by the terms described in the Notice currently in effect.


3. YOUR RIGHTS

You have the following rights regarding your PHI:

Restrictions

You may request that Practice restrict the use and disclosure of your PHI.
To request restrictions, you must make your request in writing to our Privacy Officer using the applicable Practice form.

In your request, you must tell us:
(1) what information you want to limit;
(2) whether you want to limit our use, disclosure or both; and
(3) to whom you want the restrictions to apply, for example, disclosures to your spouse.


Alternative Communications

You have the right to request that communications of PHI to you from Practice be made by particular means or at particular locations.

For instance, you might request that communications be made at your work address, instead of your home address.

Your requests must be made in writing using Practice’s form and sent to the Privacy Officer. Practice will accommodate your reasonable requests.


Inspect and Copy

Generally, you have the right to inspect and copy your PHI that Practice maintains, provided you make your request in writing to Practice’s Privacy Officer.

If you request copies of your PHI, we may impose a reasonable fee to cover copying and postage.

If we deny access to your PHI, we will explain the basis for denial and your opportunity to have your request and the denial reviewed by a licensed health care professional (who was not involved in the initial denial decision) designated as a reviewing official.

If Practice does not maintain the PHI you request and if we know where that PHI is located, we will tell you how to redirect your request.


Amendment

If you believe that your PHI maintained by Practice is incorrect or incomplete, you may ask us to correct your PHI.

Your request must be made in writing, and it must explain why you are requesting an amendment to your PHI.

We can deny your request if your request relates to PHI:
(i) not created by Practice;
(ii) not part of the records Practice maintains;
(iii) not subject to being inspected by you; or
(iv) that is accurate and complete.

If your request is denied, we will provide you a written denial that explains the reason for the denial and your rights to:
(i) file a statement disagreeing with the denial;
(ii) if you do not file a statement of disagreement, submit a request that any future disclosures of the relevant PHI be made with a copy of your request and Practice’s denial attached; and
(iii) complain about the denial.


Accounting of Disclosures

You generally have the right to request and receive a list of the disclosures of your PHI we have made at any time during the six (6) years prior to the date of your request (provided that such a list would not include disclosures made prior to April 14, 2003).

The list will not include disclosures made:
(i) for treatment, payment and health care operations;
(ii) made to you;
(iii) for Practice’s patient list;
(iv) for national security or intelligence purposes; or
(v) to law enforcement officials.

You should submit any such request to Practice’s Privacy Officer.

Practice will provide the list to you at no charge, but if you make more than one request in a year you will be charged a fee of the costs of providing the list.


Right to Copy of Notice

You have the right to receive a paper copy of this notice upon request.

To obtain a paper copy of this notice, please contact the Privacy Officer at the address and contact information stated at the end of this notice.


4. HOW WE MAY USE AND DISCLOSE MEDICAL INFORMATION ABOUT YOU

Practice may use or disclose your PHI for the purposes described below without obtaining written authorization from you.


For Treatment

Practice may use and disclose PHI while providing, coordinating or managing your medical treatment, including the disclosure of PHI for treatment activities of another health care provider.


For Payment

Practice may use and disclose PHI to bill and collect payment for the health care services provided to you.

Practice may also disclose PHI to business associates such as billing companies and claims processing companies.


For Health Care Operations

Practice may use and disclose PHI as part of its operations, including:
quality assessment, staff evaluation, training, compliance, risk management, planning, credentialing, fraud detection, and administration.


As Required by Law and Law Enforcement

Practice may use or disclose PHI when required by law or in legal proceedings, and to law enforcement agencies under proper request.


Public Health Activities

Practice may disclose PHI for public health purposes such as disease control, reporting births or deaths, or notifying exposure risks.


Health Oversight Activities

Practice may disclose PHI for audits, investigations, inspections, and compliance monitoring.


Coroners, Medical Examiners, Funeral Directors

Practice may disclose PHI for identifying a decedent or determining cause of death.


Research

Practice may use and disclose PHI for research under certain circumstances.


Serious Threat to Health or Safety

Practice may disclose PHI to prevent or lessen a serious threat.


Specialized Government Functions

Practice may disclose PHI for military, national security, or protective services.


Disclosures to You / HIPAA Compliance

Practice may disclose your PHI to you or to the Secretary of the Department of Health and Human Services.


Patient List; Marketing

Unless you object, Practice may use your PHI for patient lists and marketing purposes.


Individuals Involved in Your Care

Practice may disclose PHI to family or others involved in your care unless you object.


5. OTHER USES AND DISCLOSURES

Other uses and disclosures of your PHI will be made only with your written authorization.

You have the right to revoke your authorization in writing.


6. RIGHT TO FILE A COMPLAINT

You may submit complaints regarding your privacy rights to:

You may also contact:
Office for Civil Rights
U.S. Department of Health and Human Services

You will not be penalized for filing a complaint.


7. DISCLAIMER

Disclaimer: While the information and guidance provided in this document is believed to be current and accurate at the time of posting, it is not intended to be and should not be construed to be or relied upon as legal, financial, or consulting advice. Before use, each document should be tailored to the unique nature of your practice, including applicable state law. Consult with an attorney and other advisors. References and links to third parties do not constitute an endorsement or sponsorship by the AMA, and the AMA hereby disclaims all express and implied warranties of any kind in the information provided.

Naonee’s Healthcare Services GLP-1 Consent

This consent form outlines the agreement between the patient and Medical Excellence Wellness and Healthcare regarding the use of compounded glucagon-like peptide-1 (GLP- 1) receptor agonist medications as part of the patient’s weight management plan. Patients must understand the benefits, risks, and responsibilities associated with GLP-1 agonists to ensure safe and effective treatment.

The following information aims to educate the patient on the risks associated with the use of GLP-1 agonists, facilitating understanding and consent to a treatment contract. This consent form is intended to serve as confirmation of informed consent for compounded glucagon-like peptide-1 receptor agonists Injections (Semaglutide or Tirzepatide), which are prescription medications used for weight loss.


About GLP-1 Agonists

GLP-1 (Glucagon-Like Peptide-1) is a hormone produced in the intestines in response to food intake. It plays a crucial role in regulating blood sugar levels by stimulating insulin secretion in a glucose-dependent manner (meaning it only increases insulin release when blood sugar levels are elevated). GLP-1 also suppresses glucagon secretion (a hormone that increases blood sugar levels) and slows down gastric emptying, which helps to control postprandial (after-meal) glucose levels.


Mechanism of Action

GLP-1 receptor agonists bind and activate GLP-1 receptors on pancreatic beta cells (which produce insulin) and other tissues involved in glucose metabolism. This activation leads to increased insulin secretion in response to meals, reduced glucagon secretion (which decreases glucose production by the liver), and slowed gastric emptying (which helps to prevent rapid rises in blood sugar after eating).


Clinical Use of GLP-1 Agonists

Clinical Use: GLP-1 receptor agonists are typically prescribed along with a reduced-calorie diet and increased physical activity to individuals with type 2 diabetes who have not achieved adequate blood sugar control with other oral medications. GLP-1 agonists, originally developed for the management of type 2 diabetes, have also been approved for weight management due to their beneficial effects on appetite control and metabolism.


Benefits of GLP-1 Agonists

• Effective in promoting weight loss by reducing appetite and increasing feelings of fullness.
• It helps improve blood sugar control by enhancing insulin secretion in response to meals.
• Lowers the risk of cardiovascular events, such as heart attack or stroke, in people with type 2 diabetes.
• May improve metabolic health by reducing inflammation and oxidative stress.
• Typically associated with a lower risk of hypoglycemia compared to other diabetes medications.


Side Effects and Risks
Mild side effects may include:

• Nausea: An initial side effect that often improves over time.
• Gastroesophageal Reflux Disease (GERD): Symptoms of acid reflux or heartburn.
• Vomiting: Occasional vomiting, especially early in treatment.
• Diarrhea: Less common but can occur.
• Constipation: Less common but can occur.
• Abdominal Distention: Feeling of bloating or fullness in the abdomen.
• Abdominal Pain: Discomfort or pain in the abdomen.
• Dyspepsia: General discomfort in the upper abdomen.
• Belching: Excessive air or gas in the stomach, leading to burping.
• Flatulence: Increased gas production and passing of gas.
• Headache: Mild to moderate headaches.
• Fatigue: Feelings of tiredness or lack of energy.
• Dizziness: Occasional dizziness or lightheadedness.
• Hypoglycemia: Less common than with other diabetes medications, but can occur, especially when combined with insulin or sulfonylureas.
• Injection Site Reactions: Mild reactions such as redness, bruising, swelling, or itching at the injection site.


In rare cases, serious side effects may include:

• Allergic Reactions: Although rare, allergic reactions including serious hypersensitivity reactions (e.g., anaphylaxis) have been reported with GLP-1 agonists. Patients should seek immediate medical attention if they experience symptoms such as rash, itching, swelling, dizziness, or difficulty breathing.

• Pancreatitis: There is a rare but serious risk of pancreatitis (inflammation of the pancreas) associated with GLP-1 agonists. Symptoms of pancreatitis include severe abdominal pain that may radiate to the back, nausea, and vomiting. Patients should seek immediate medical attention if they experience these symptoms.

• Acute Kidney Injury: In rare cases, GLP-1 agonists have been associated with acute kidney injury. Patients should be monitored for signs of decreased kidney function, such as changes in urine output, swelling in the legs or ankles, and fatigue.

• Thyroid C-Cell Tumors: Studies in rodents have shown an increased risk of thyroid C-cell tumors with some GLP-1 agonists. While this risk has not been definitively established in humans, it is a concern that requires monitoring, particularly in individuals with a personal or family history of medullary thyroid carcinoma (MTC).


Contraindications: Do not take GLP-1 agonist medications if:

• You have a personal or family history of Thyroid C-cell tumors, including Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
• You are allergic to Semaglutide, Tirzepatide, BPC-157, SGLT2 Inhibitors, or any other GLP-1 Agonist.
• You are a Type 1 Diabetic.
• You have diabetes and are taking other blood sugar-lowering medications without first consulting your PCP or endocrinologist, and providers from Medical Excellence Wellness and Healthcare
• You have a history of pancreatitis.
• You have a history of gallbladder disease.
• You have kidney disease or are on dialysis.
• You are pregnant, plan to become pregnant, or are breastfeeding.
• You have other concerning allergies.
• You are taking any other GLP-1 agonist medication.
• You have a history of diabetic retinopathy or diabetes.

.


Medical History

Before using this medication, provide your complete medical history and a list of current medications to the Medical Excellence Wellness and Healthcare clinician. Specifically, inform your clinician about any medications that may lower your blood sugar.


Drug Interactions

GLP-1 medications may delay gastric emptying, affecting the absorption of other oral medications. Monitor and report side effects to your clinician. Please inform the Medical Excellence Wellness and Healthcare clinician about any medications you are currently taking that may affect blood sugar levels.

Possible drug interactions with GLP-1 agonists include insulin and sulfonylureas due to the increased risk of hypoglycemia (low blood sugar) and corticosteroids due to the increased risk of hyperglycemia (high blood sugar) which may necessitate the need for dose adjustment.

Patient Acknowledgment and Consent

By signing this form, I certify that:

• I certify that I have read the contents of this form in its entirety. I have had the opportunity to ask questions and have had my questions answered. An ample opportunity has been offered to me to ask questions and seek clarification of anything unclear to me. I fully understand the contents of this form and have no further questions.

• I have informed Medical Excellence Wellness and Healthcare clinicians of all medical conditions, any known allergies to drugs or other substances, and any past adverse reactions I’ve experienced. I have informed my provider of all medications (including prescription drugs, over-the-counter medications, vitamins, and supplements) I am currently taking.

• I understand this medication must be self-injected in the subcutaneous tissues once weekly.

• I understand this medication must be kept refrigerated.

• I will not share this medication (or needles) with others and agree to dispose of needles safely.

• I will inform my provider if I become pregnant or am breastfeeding.

• I will notify my provider if I experience side effects or if I am having trouble with administration. Medical Excellence Wellness and Healthcare clinicians can provide guidance on managing side effects and adjusting treatment plans if needed.

• I understand this prescription comes from a compounding pharmacy and is not FDA-approved. I have been informed that the manufacturing facility is FDA monitored and the medication is third-party tested.

• I am aware of the possible side effects. I understand this medication could be harmful if taken inappropriately and should be used only as prescribed.

• I acknowledge that no guarantees have been made to me concerning my results.

• I consent to the use of GLP-1 agonists, and I understand that my treatment with such medications will be governed by this agreement. I understand and accept the risks, conditions, and terms of the proposed treatment as presented.

• I release Medical Excellence Wellness and Healthcare from any liability related to my receipt of compounded semaglutide.

 

• I am signing this form voluntarily, and I have full right and power to be bound by this agreement. I understand and will abide by this policy. By signing this form, I voluntarily give my consent for treatment and accept the associated risks.